Skip to main content

Ashutosh Chilkoti

Alan L. Kaganov Distinguished Professor of Biomedical Engineering
Biomedical Engineering
Box 90281, Durham, NC 27708-0281
3381 CIEMAS, Durham, NC 27708

Overview


Ashutosh Chilkoti is the Alan L. Kaganov Professor of Biomedical Engineering and Chair of the Department of Biomedical Engineering at Duke University.

My research in biomolecular engineering and biointerface science focuses on the development of new molecular tools and technologies that borrow from molecular biology, protein engineering, polymer chemistry and surface science that we then exploit for the development of applications that span the range from bioseparations, plasmonic biosensors, low-cost clinical diagnostics, and drug delivery.

Current Appointments & Affiliations


Alan L. Kaganov Distinguished Professor of Biomedical Engineering · 2016 - Present Biomedical Engineering, Pratt School of Engineering
Professor of Biomedical Engineering · 2006 - Present Biomedical Engineering, Pratt School of Engineering
Professor in the Department of Chemistry · 2009 - Present Chemistry, Trinity College of Arts & Sciences
Research Professor of Global Health · 2020 - Present Duke Global Health Institute, University Institutes and Centers
Member of the Duke Cancer Institute · 1996 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published October 25, 2024
Hard-Earned Lessons from Spinning Out a Startup Company from a University
Published July 12, 2023
Low-Cost, Gravity-Powered Approach for Biomedical Devices
Published March 10, 2023
Inside the Journey of a Duke Biotech Start-Up

View All News

Recent Publications


Genetically Encoded Sterol-Modification of a Synthetic Intrinsically Disordered Protein Drives Its Self-Assembly Into Diverse Morphologies.

Journal Article Small (Weinheim an der Bergstrasse, Germany) · April 2026 Post-translational modifications (PTMs) of proteins are used by natural systems to expand beyond the 20 canonical amino acids. The variation introduced at the sequence level by PTMs after expression leads to changes in both the structure and function of pr ... Full text Cite

All-PEG-Like Block Copolymers Self-Assemble into Stealth Nanocarriers for Drug Delivery.

Journal Article Advanced science (Weinheim, Baden-Wurttemberg, Germany) · March 2026 Poly(oligo(ethylene glycol) methyl ether methacrylate) (POEGMA) is a stealth polymer that does not exhibit polyethylene glycol (PEG) antigenicity. Herein, we engineered self-assembling nanoparticles composed entirely of POEGMA by designing AB diblock copol ... Full text Cite

Controlling Release Kinetics of an Adjuvant from a Depot Improves the Efficacy of Local Immunotherapy in Metastatic Cancer.

Journal Article Adv Sci (Weinh) · October 2025 Biomaterials can improve cancer immunotherapies by controlling their release and thereby optimizing their time-dependent engagement of the immune system. In this study, an approach is described to control the release of a potent immunostimulant-CpG oligode ... Full text Link to item Cite
View All Publications

Recent Grants


Pharmacological Sciences Training Program

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2025 - 2030

Breast Cancer Diagnostic Kit to Improve Early Diagnosis in Uganda

ResearchPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2024 - 2029

Development, Clinical Validation, and Readiness for Implementation of a Novel Mp1p D4 Point of Care Test for Rapid Diagnosis of Talaromycosis

ResearchCo-Principal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2023 - 2028

View All Grants

Education


University of Washington · 1991 Ph.D.